1. Updated FAQ on medical repricing interim measures is now available.

 

2. We acknowledge the recent press statement issued by Bank Negara Malaysia regarding interim measures to address the contribution revisions for medical plans. As a responsible takaful operator, we take this matter seriously and remain committed to act in the best interests of our customers. These interim measures aim to provide our customers the flexibility to better navigate and manage their financials while preserving their medical coverage.

 

We understand the importance of keeping our customers informed and will provide updates as soon as new information becomes available.

 

In the meantime, we encourage you to click here for more details or contact our dedicated customer service line at 1300-13-8338 and press 6 after language selection, from Monday to Friday, 8.30am - 5.15pm (except Public Holiday) for further assistance.

 

3. Temporary Suspension of New Direct Debit Authorisation (DDA) Applications

Please be informed that the submission of new Direct Debit Authorisation (DDA) applications will be temporarily suspended effective from 16th January 2025 until further notice. Click here for more details.

 

4.   2024 Contribution Statements and Investment-linked Funds Report are now available

The Contribution Statements and Investment-linked Funds Report for the year 2024 are now available. Click here for more details.

Frequently Asked Questions


NOTE:


The products mentioned in this FAQ specifically refer to impacted i-Great MediMax and i-Great MediHarapan customers.


 

i. Spreading out the Tabarru’ charges and contribution revision quantum

The revision of Tabarru’ charges and contribution will be spread out during the interim period* where at least 80% of the Takaful participants are expected to experience Tabarru’ charges and contribution increment of less than 10%. The revision will be re-assessed after the interim period ends and may be higher or lower than current projection based on effectiveness of cost-containment strategies that will be put in place.

*The Interim Period is defined as the MHIT repricing exercises commencing in 2024, 2025 and 2026.

ii. Temporary pause for the revision of Tabarru’ charges and contribution

For person covered aged 60 years old and above who participated under the minimum plan within the range of medical plan offered (refer to FAQ 3), the revision of Tabarru’ charges and contribution will be temporary paused for one year. The revision will resume on the subsequent year with consideration of interim measures.

iii. Alternative MHIT Product Offering

Alternative MHIT product will be offered by the end of 2025 as additional option(s) for medical plans that are being repriced.

The above is not applicable if the revision of Tabarru’ charges and contribution is due to change in age band.

The new Tabarru’ charges and contribution rate will take effect on your certificate anniversary date on or after 1 June 2025 for the following products.:

Traditional Plan

  • i-Great MediMax (0718 - 0720)
  • i-Great MediHarapan (0739 & 0757)

Example 1: 

Next Anniversary Date: 20 May 2025. The new Tabarru’ and contribution rate will be effective on 20 May 2026. 

Example 2: 

Next Anniversary Date: 1 June 2025. The new Tabarru’ and contribution rate will be effective on 1 June 2025.

For reinstatement on or after 1 June 2025, the new Tabarru’ charges and contribution rate will be effective immediately after the reinstatement and standard waiting period will be apply.

You may refer below to identify the minimum plan:

  • i-Great MediMax: Room & Board 150
  • i-Great MediHarapan: Room & Board 150

For Age Next Birthday (ANB) 60 and above with minimum plan

For person covered aged 60 years old and above with minimum medical plan selection, temporary pause will apply for 1 year from your certificate anniversary.

On your next certificate anniversary after 1 year of the temporary pause, the repricing exercise will resume with the revision of Tabarru’ charges and contribution will factor in the spread out of repricing quantum during the interim period.

For Others

The revision of Tabarru’ charges and contribution will factor in the spread out of repricing quantum during the interim period. The revision will take effect on your next certificate anniversary.

Yes, you may proceed to discuss with your Takaful Advisor to explore to downgrade your medical plan to a lower coverage plan to have lower Tabarru’ charges and contribution.

However, we remind that any changes to your Takaful benefits will have an impact on the comprehensiveness of your protection. 

The conversions are only allowed for switching to new medical plan with similar Room & Board (R&B) limit or lower R&B. No waiting period will be applicable for the conversions and normal underwriting will be apply.

You need to ensure your old certificate is still inforce and paid up to date for seamless transition. For further assistance, you may discuss with your Takaful Advisor on this conversion.

Below will be the applicable medical plans for conversion which attached under i-Great Evo:    

  • i-Medi Shield Rider     
  • i-Medi Shield Step Up Rider

Revision of Tabarru’ charges (i.e. repricing) is mainly driven by deteriorating claim experience due to rising medical costs, increase in diagnosis of chronic or lifestyle diseases which leads to a higher frequency of people seeking healthcare treatments, increase in doctor’s fees or laboratory charges and new/more advanced medical treatments and prescription of drugs. 

As claims are paid from the Tabarru’ Fund, the rising trend of claims has reduced the Tabarru’ Fund considerably and it may not be sufficient to cover future claims. Tabarru’ charges for respective medical plans will need to be revised to ensure its sustainability. Without the medical repricing exercise, Tabarru’ Fund may deplete, and it poses a real risk that it will be difficult to pay future claims.

Takaful is based on the Tabarru’ concept where a portion of the contribution collected is donated to the Tabarru’ Fund to pay for claims.

As a result, all Takaful participants will be affected to ensure the Tabarru’ Fund will be able to sustain claim payouts for all Takaful participants. This is aligned with the concept of mutual cooperation to help one another in the event of misfortune regardless whether you have made a claim before or otherwise.

This revision is made mainly on the Tabarru’ Charges and contribution rate. All other terms and conditions of the certificate remain unchanged.

The utilisation rate, average claim amount and medical inflation for the impacted products are as below.

Traditional Plan

Medical Plan Utilisation Rate  Average Claims Amount  3-year Average Medical Cost Inflation
i-Great MediMax 207 out of 1,000 takaful participants have made claims compared to 204 out of 1,000 takaful participants 1 year ago
Increased from RM5,895 to RM6,699
25% per annum
i-Great MediHarapan 170 out of 1,000 takaful participants have made claims compared to 63 out of 1,000 takaful participants 5 year ago
Increased from RM4,546 to RM5,586
37% per annum

 


The benefit(s) payable under eligible certificate/product is protected by PIDM up to limits. PROTECTION BY PIDM ON BENEFITS PAYABLE FROM THE UNIT PORTION OF THIS CERTIFICATE/PRODUCT IS SUBJECT TO LIMITATIONS. Please refer to PIDM’s TIPS Brochure or contact Great Eastern Takaful Berhad or PIDM (visit www.pidm.gov.my).